ShePrep

Lupus in Pregnancy

Systemic lupus erythematosus makes pregnancy higher risk but usually still successful. Care is planned around disease activity at conception, antibody status, and kidney involvement. NICE guideline NG121 asks for kidney disease due to lupus nephritis to have an intrapartum plan agreed as early as possible in pregnancy.

Timing is the intervention

Almost every serious source on lupus and pregnancy says the same thing first: conceive during a period of quiet disease. The usual framing is at least six months of stable, inactive lupus, particularly where the kidneys have been involved. That is not a rule you can apply retrospectively, and if you are reading this already pregnant with active disease, the response is an urgent joint review rather than alarm.

The NHS lupus pages describe SLE as a long-term condition causing inflammation in joints, skin and other organs, that flares and settles. Pregnancy sits inside that pattern rather than outside it. Most women with lupus have successful pregnancies; the care is designed around the minority of situations that go wrong, and around detecting them early.

The antibody results that change your care

Three antibody groups get checked, and each does something different. Knowing which of them you have explains most of what your team does next.

Anti-Ro (SSA) and anti-La (SSB)

These cross the placenta and can affect the baby's heart conduction system, causing neonatal lupus and, rarely, congenital heart block. Where they are present, fetal heart rate monitoring or serial fetal echocardiography is usually arranged through the second trimester. The important honesty here is about the denominator: congenital heart block is uncommon even among antibody-positive pregnancies, but it is serious when it happens, which is why monitoring is offered rather than reassurance alone. If you are quoted a bare percentage without a source and a population, treat it with suspicion.

Antiphospholipid antibodies

Lupus anticoagulant, anticardiolipin and anti-beta-2 glycoprotein I antibodies are tested because they, not lupus itself, drive much of the pregnancy loss and thrombosis risk. ACOG Practice Bulletin No. 132 defines antiphospholipid syndrome as requiring "at least one clinical and one laboratory criterion", and notes that roughly 70% of people with APS are female, so it is "reasonably prevalent among women of reproductive age". A positive antibody test on its own is not the syndrome, and being told you have antibodies is not the same as being told you have APS.

Anti-double-stranded DNA and complement

These are followed serially as activity markers, because the usual clinical signs of a flare, such as fatigue, joint pain, hair shedding and breathlessness, are also ordinary features of pregnancy.

Flare or pre-eclampsia: the hardest call in lupus care

Active lupus nephritis and pre-eclampsia can both produce rising blood pressure, protein in the urine and falling platelets, and the treatments point in opposite directions. One is treated by suppressing the immune system; the other is only cured by birth. This is the main reason lupus pregnancies are consultant-led and why baseline blood and urine results in early pregnancy matter so much. Without a baseline urine protein:creatinine ratio, there is nothing to compare a third-trimester result to.

NICE guideline NG133 sets out how hypertension in pregnancy is diagnosed and managed, including the threshold-based approach to blood pressure and the assessment of proteinuria. In lupus, those thresholds are read alongside your rheumatology results rather than in isolation.

Kidney involvement changes the plan explicitly

NICE guideline NG121 names lupus directly. Recommendation 1.8.10 says that "as early as possible during pregnancy", intrapartum care should be planned for women with kidney disease due to lupus nephritis, vasculitis or glomerulonephritis, together with the woman and a clinician with expertise in managing renal conditions in pregnant women. That is a named, early, written plan, not a decision made on the day.

NG121 also sets birth timing expectations by kidney stage, including considering planned birth by 40 weeks plus 0 days for chronic kidney disease stage 1 with nephrotic-range proteinuria or stages 2 to 4 with stable function. NICE guideline NG203 defines the staging those recommendations depend on. If lupus has affected your kidneys, ask which stage you are considered to be at, because that single answer drives most of your birth planning.

Medicines: named, not dosed

Lupus treatment in pregnancy generally continues rather than stops, and the medicines involved include hydroxychloroquine, corticosteroids, azathioprine, tacrolimus and ciclosporin, alongside low-dose aspirin for pre-eclampsia risk reduction and, where antiphospholipid syndrome is confirmed, heparin. Mycophenolate, methotrexate and cyclophosphamide are the drugs that require planned withdrawal before conception. No doses appear on this page; those decisions belong to your rheumatology team and change with your disease.

The point worth internalising is that stopping hydroxychloroquine on discovering a pregnancy is a recognised trigger for flare, and it is a decision to discuss urgently rather than make alone.

What monitoring to expect

Expect more appointments than a routine pregnancy: joint rheumatology and obstetric review, regular blood pressure and urine testing, serial bloods including full blood count, renal function, complement and anti-dsDNA, and additional growth scans because lupus is associated with fetal growth restriction and placental problems. Where anti-Ro or anti-La are positive, add fetal cardiac monitoring in the second trimester.

Postnatally, flare risk continues, so agree in advance who is reviewing you and when. If you have antiphospholipid antibodies, thromboprophylaxis after birth is a specific question to have answered before you go home.

Birth planning and the postnatal weeks

Lupus alone does not decide how you give birth. NICE guideline NG121 asks for the intrapartum plan to be agreed in advance by a multidisciplinary team, and for lupus the specific items are your current steroid and immunosuppressant treatment, whether kidney involvement changes your fluid management, and whether any anticoagulation affects the timing of an epidural or spinal. Those three answers belong in your notes before labour rather than being worked out during it.

The weeks after birth deserve their own plan. Flare is common in this period, sleep loss makes fatigue impossible to interpret, and the appointment most easily missed is the rheumatology one. Book it before you give birth. If you are breastfeeding, ask which of your medicines are compatible rather than assuming either way, because the answer differs drug by drug and is usually more permissive than people expect.

Sources

  1. Lupus NHS, accessed
  2. Intrapartum care for women with existing medical conditions or obstetric complications and their babies (NG121) NICE, accessed
  3. Hypertension in pregnancy: diagnosis and management (NG133) NICE, accessed
  4. Antiphospholipid Syndrome (Practice Bulletin No. 132) American College of Obstetricians and Gynecologists, accessed
  5. Chronic kidney disease: assessment and management (NG203) NICE, accessed
  6. Antiphospholipid syndrome NHS, accessed